Last reviewed · How we verify
NCT05855837
Appetite Responses to Cereal Products
NA trial testing Ready to Eat Cereal in Satisfaction, Consumer in 228 participants. Completed in 30 August 2023.
9 June 2023
Quick facts
| Lead sponsor | General Mills |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 228 |
| Start date | 5 June 2023 |
| Primary completion | 9 June 2023 |
| Estimated completion | 30 August 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Ready to Eat Cereal
Conditions studied
- Satisfaction, Consumer — all drugs for Satisfaction, Consumer →
Sponsor
General Mills
Who can join
Adults 18 to 70, any sex, with Satisfaction, Consumer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this clinical trial is to investigate appetite responses to 2 cereal products in healthy adults.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05855837
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other General Mills trials
Trials by the same sponsor.
- NCT06569043 — Appetite Responses to Breakfast Bar Product · NA · completed
- NCT05870891 — Equivalent Glycemic Load and Insulinemic Response Elicited by 7 Low Carbohydrate Products in Healthy Adults · NA · completed
- NCT05287516 — Validation of a Digital Visual Analogue Scale for Appetite Measurement · NA · completed
- NCT04740112 — Beta-glucan, Product Claims and Satiety · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05855837 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by General Mills
- Last refreshed: 26 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05855837.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing